CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 29

Industry reads hand-picked by our editors

Mar 04, 2025

The Wall Street Journal
RFK Jr.’s Health Department Heightens Scrutiny of Vaccines
Reuters
Bayer faces investors’ impatience ahead of fourth-quarter results
FirstWord Pharma
With Dupixent nipping at its heels, Novartis bets up to $777M on Kyorin’s itch candidate

Mar 03, 2025

Reuters
India’s Sun Pharma aims to launch its obesity drug in five years, managing director says
Axios
RFK Jr. move to kill public comment roils providers
Fierce Pharma
Lilly ads promote ‘healthy skepticism’ toward compounded drugs

Feb 28, 2025

The Atlantic
Inside the Collapse at the NIH
Reuters
Measles death in Texas puts Kennedy’s vaccine views to the test
Endpoints News
Trump’s science crackdown hits rare disease medicine: ‘We need to sit down with Elon Musk’

Feb 27, 2025

Bloomberg
Trump Team Considers Pulling Funding for Moderna Bird Flu Vaccine
C&EN
Amid deletions and lawsuits, groups race to save federal data
Fierce Pharma
Epidiolex maker Jazz reviewing M&A deal options of ‘various sizes,’ CFO says

Feb 26, 2025

The Financial Times
The political rise of the anti-vax movement
Los Angeles Times
Killing 166 million birds hasn’t helped poultry farmers stop H5N1. Is there a better way?
The New York Times
Musk Cost-Cutting Effort Is Being Guided by Health Entrepreneur
BioCentury
Tough path for pill penalty fix

Feb 25, 2025

Fierce Pharma
Of 22 top drugmakers, 21 showed revenue increases in Q4
Axios
Rare disease meeting gets pushed off by HHS
FirstWord Pharma
Fresh off FDA approval, Axsome’s migraine med proves mettle against CGRPs
KFF Health News
With RFK Jr. in Charge, Supplement Makers See Chance To Cash In

Feb 24, 2025

Bloomberg
Trump Told Drugmakers to Move Production to US or Face Tariffs
Fierce Biotech
CBER deputy director departs amid mass exodus
Axios
The businesses hoping to boom under an RFK Jr.-led HHS
Stat
Post vaccination syndrome: Science weaponized for political ends?

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Survey Report
The Evolution of Outsourced Buffer Production in Manufacturing Custom content for Thermo Fisher Scientific
Playbook
How to Unlock A Successful ICH E6(R3) Implementation Custom content for WCG
Playbook
Successful Biomarker-Driven Cancer Drug Development Custom content for Labcorp

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Revolutionizing Next Generation Gene Therapies with On-Demand Large DNA Construct Synthesis and Novel, Designable Delivery Vehicles Webinar - on demand • Provided by Ansa Biotechnologies
Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce
Enhance Drug Discovery with CADD and Agentic AI on Rescale, AWS, and NVIDIA Webinar - on demand • Provided by Amazon Web Services (AWS), NVIDIA, and Rescale

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.